Multispecialty
COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Join experts in the medical field for free CME webinars covering what we know about the coronavirus outbreak.
9/16/2020 - COVID-19 and Substance Abuse Part 2
Dr. Paul Auwaerter continues his interview with Dr. Kathleen Brady, President of the International Society of Addiction Medicine (ISAM), about the impact of COVID-19 on people with substance use disorders. Topics: *Changes to treatment regulations during the pandemic *How providers can help treat substance use disorders *Resources for treating addiction *Using telehealth to deliver substance use therapy *Tips for helping patients recognize a substance use issue
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
kathleen brady, MD, PhD
Director, South Carolina Clinical and Translational Science Institute
Distinguished University Professor
Vice President for Research
Medical University of South Carolina
Charleston, SC
View All
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until September 16, 2021. PAs should only claim credit commensurate with the extent of their participation.